This article reveals that the U.S. Food and Drug Administration (FDA) licensed GeneGo's platform, MetaCore, for use by FDA researchers reviewing genomic data. Pathway companies blend data-mining techniques with public or proprietary databases to identify pathways of interest. Some of GeneGo's customers are enumerated. The platform is a third GeneGo product aimed at toxicogenomics.